These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. I've heard that new medications to treat wet age-related macular degeneration (AMD) are available. Are these new medications better than current treatments? Johns Hopkins Med Lett Health After 50; 2006 Dec; 18(10):8. PubMed ID: 17290531 [No Abstract] [Full Text] [Related]
70. Should avastin be used to treat age-related macular degeneration in the NHS?--No. Chong NV Eye (Lond); 2009 Jun; 23(6):1250-3. PubMed ID: 19407836 [No Abstract] [Full Text] [Related]
71. Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration. Barouch FC; Miller JW Int Ophthalmol Clin; 2004; 44(3):23-32. PubMed ID: 15211174 [No Abstract] [Full Text] [Related]
72. CATT: Into the eye of a tiger. Sears J; Bena J; Singh AD Br J Ophthalmol; 2011 Jun; 95(6):761. PubMed ID: 21602481 [No Abstract] [Full Text] [Related]
73. Should Avastin be used to treat age-related macular degeneration in the NHS?--Yes. Raftery J; Dent L Eye (Lond); 2009 Jun; 23(6):1247-9. PubMed ID: 19407834 [No Abstract] [Full Text] [Related]
78. [Avastin is not the same as Lucentis, and Lucentis is not the same as Avastin]. Asensio-Sánchez VM Arch Soc Esp Oftalmol; 2009 Sep; 84(9):427. PubMed ID: 19809922 [No Abstract] [Full Text] [Related]
79. A review of drug options in age-related macular degeneration therapy and potential new agents. Yeoh J; Sims J; Guymer RH Expert Opin Pharmacother; 2006 Dec; 7(17):2355-68. PubMed ID: 17109611 [TBL] [Abstract][Full Text] [Related]